Invention Grant
US07834060B2 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
有权
施用6- [3-（1-金刚烷基）-4-甲氧基苯基] -2-萘甲酸用于治疗皮肤病
![Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders](/docs/US/2010-11-16/US07834060B2/abs.jpg.600x600.jpg)
- Patent Title: Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
- Patent Title (中): 施用6- [3-（1-金刚烷基）-4-甲氧基苯基] -2-萘甲酸用于治疗皮肤病
-
Application No.: US12437008Application Date: 2009-05-07
-
Publication No.: US07834060B2Publication Date: 2010-11-16
- Inventor: Michael Graeber , Janusz Czernielewski
- Applicant: Michael Graeber , Janusz Czernielewski
- Applicant Address: FR Biot
- Assignee: Galderma Research & Development
- Current Assignee: Galderma Research & Development
- Current Assignee Address: FR Biot
- Agency: Buchanan Ingersoll & Rooney PC
- Priority: FR0203070 20020312
- Main IPC: A01N37/10
- IPC: A01N37/10 ; A01N37/00 ; A61K31/19 ; A61K31/185 ; A61K8/02
![Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders](/abs-image/US/2010/11/16/US07834060B2/abs.jpg.150x150.jpg)
Abstract:
Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions.
Public/Granted literature
Information query
